Home › Funds › Parkman Healthcare Partners LLC › SDGR
Parkman Healthcare Partners LLC position in SDGR
SCHRODINGER INC · Health Care
Parkman Healthcare Partners LLC reported holding 375,000 shares of SDGR (SCHRODINGER INC) in its Q3 2026 13F filing — a position valued at US$11.6M, representing 1.05% of its reported portfolio and ranking #39 among its reported holdings. Parkman Healthcare Partners LLC has disclosed SDGR holdings in 11 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Parkman Healthcare Partners LLC's SDGR position evolved
Parkman Healthcare Partners LLC first disclosed a stake in SDGR in Q3 2023 at 368,654 shares (US$10.4M). The position peaked in Q1 2024 at 1,000,014 shares, worth US$27.0M. Across 11 filings, Parkman Healthcare Partners LLC increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 375,000 shares valued at US$11.6M. Notable position changes include a 147% increase in Q1 2024 (shares fell 28% over the following quarter), a 28% trim in Q2 2024 (shares fell 4% over the following quarter), a 42% trim in Q3 2025 (shares fell 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 368.65K | $10.42M | New |
| Q4 2023 | 405.23K | $14.51M | Add |
| Q1 2024 | 1.00M | $27.00M | Add |
| Q2 2024 | 721.37K | $13.95M | Reduce |
| Q3 2024 | 559.11K | $10.37M | Reduce |
| Q4 2024 | 563.09K | $10.86M | Add |
| Q1 2025 | 481.47K | $9.50M | Reduce |
| Q2 2025 | 587.56K | $11.82M | Add |
| Q3 2025 | 340.19K | $6.82M | Reduce |
| Q4 2025 | 298.94K | $5.35M | Reduce |
| Q3 2026 | 375.00K | $11.64M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SDGR and 13F data
SDGR (SCHRODINGER INC) is a Health Care company. 27 other funds we track also report a position in SDGR — the largest reported positions include Gates Foundation Trust (US$113.5M), Rubric Capital Management LP (US$104.0M), Amova Asset Management Americas, Inc. (US$79.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SDGR
- Gates Foundation Trust 6.98M sh · $113.45M · Q2 2026
- Rubric Capital Management LP 6.40M sh · $104.00M · Q2 2026
- Amova Asset Management Americas, Inc. 2.55M sh · $79.24M · Q3 2026
- ARK Invest 2.37M sh · $73.74M · Q3 2026
More on Parkman Healthcare Partners LLC
FAQ
How long has Parkman Healthcare Partners LLC held SDGR?
Parkman Healthcare Partners LLC has disclosed SDGR holdings in 11 of the last 13 reported quarters, going back to Q3 2023.
What is Parkman Healthcare Partners LLC's current position in SDGR?
As of Q3 2026, Parkman Healthcare Partners LLC holds 375.00K shares of SDGR (SCHRODINGER INC), valued at $11.64M, representing 1.05% of its reported portfolio and ranking #39.
Has Parkman Healthcare Partners LLC been buying or selling SDGR?
In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC newly opened its position in SDGR. The position peaked in Q1 2024 at 1.00M shares.
Which other funds hold SDGR?
Other major institutional holders of SDGR include Gates Foundation Trust, Rubric Capital Management LP, Amova Asset Management Americas, Inc., among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.